FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Burris Mei Zhang Lu
(Last) (First) (Middle)
C/O PRECISION BIOSCIENCES, INC.
302 E. PETTIGREW STREET, SUITE A-100
(Street)
DURHAM NC 27701
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/01/2026 		3. Issuer Name and Ticker or Trading Symbol
PRECISION BIOSCIENCES INC [ DTIL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chielf Accounting Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 5,115
D
 
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)   (1) 05/01/2029 Common Stock 945 378 D  
Employee Stock Option (Right to Buy)   (1) 08/20/2030 Common Stock 214 174.9 D  
Employee Stock Option (Right to Buy)   (1) 06/06/2031 Common Stock 403 340.2 D  
Employee Stock Option (Right to Buy)   (1) 03/02/2032 Common Stock 778 122.4 D  
Restricted Stock Units   (2)   (2) Common Stock 11,288 (3) D  
Restricted Stock Units   (4)   (4) Common Stock 30,129 (3) D  
Explanation of Responses:
1. The stock options are fully vested and exercisable as of the date of this report.
2. On July 24, 2025, the reporting person was granted 16,932 restricted stock units ("RSUs"), which vest in three substantially equal annual installments beginning on February 24, 2026, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
3. The Reporting Person was granted RSUs, which each represents a contingent right to receive one share of the Company's Common Stock.
4. On June 1, 2026, the reporting person was granted 30,129 RSUs, which vest in three substantially equal annual installments beginning on February 22, 2027, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Dario Scimeca, Attorney-in-Fact for Mei Burris 08/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-24